The University at Buffalo is running a new multi-site study for adults that have high-risk liver disease. Adults living with high-risk liver disease have a greater chance of experiencing serious complications from the disease. The research team is looking to see if a new medication can help to treat high-risk liver disease. Read More

-Adults 18 years or older
-Have been diagnosed with high-risk liver disease
-Not currently pregnant

The University at Buffalo (UB) is looking for adults with non-alcoholic fatty liver disease (NAFLD) for a new study. NAFLD is caused by the buildup of fat in the liver. For some people, this build-up can cause swelling and damage to liver cells. The goal of the study is to see if a new medicine can help treat NAFLD. Read More

*Adult males or nonpregnant females subjects with F2 or F2 fibrosis due to NASH/MASH confirmed by liver biopsy.
*Previous or current history of T2D or 2 out of the 4 components of metabolic syndrome.
*BMI of 25 kg/m2 or greater.
Cohort 1 - must have a FibroScan LSM > 8.5 kPa, ELF > or = 9.8, AST >35 U/L at screening
Cohort 2 - must have a FibroScan LSM >9 kPa, ELF > or =9.8, AS...

The University at Buffalo is recruiting adults living with compensated liver cirrhosis for a 5-year study. People with this diagnosis have scarring on their livers but their livers still function normally. Read More

-Adults 18 years or older
-Have been diagnosed with liver cirrhosis due to nonalcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH)
-Not currently pregnant